Evidence map›Paper›PMID 26470779›Full record

ReviewHarm reduction journal2015

Facilitating a transition from compulsory detention of people who use drugs towards voluntary community-based drug dependence treatment and support services in Asia.

Pascal Tanguay, Adeeba Kamarulzaman, Apinun Aramrattana, Alex Wodak, Nicholas Thomson, Robert Ali, Gino Vumbaca, Gloria Lai, Anand Chabungbam

Abstract readReview
In one paragraph

Review in Harm reduction journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Confronting the HIV, Tuberculosis, Addiction, and Incarceration Syndemic in Southeast Asia: Lessons Learned from Malaysia.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2016
    Review
  12. Drug Abuse, HIV, and HCV in Asian Countries.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2016
    Review
  13. Article
  14. Southeast Asia in focus: stemming the reawakening of prohibitionism.Journal of the International AIDS Society · 2016
    Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pascal TanguayOzone Foundation, Bangkok, Thailand. pascalembours@gmail.com.
Adeeba KamarulzamanUniversity of Malaya, Kuala Lumpur, Malaysia. adeeba@ummc.edu.my.
Apinun AramrattanaDepartment of Family Medicine, Chiang Mai University, Chiang Mai, Thailand. apinun.aramrat@gmail.com.
Alex WodakAlcohol and Drug Service, St Vincent's Hospital, Sydney, Australia. alex.wodak@gmail.com.
Nicholas ThomsonUniversity of Melbourne's School of Population and Global Health, Melbourne, Australia. nicholast@unimelb.edu.au.
Robert AliAustralian National Advisory Council on Alcohol & Drugs (ANACAD), Adelaide, Australia. robert.ali@adelaide.edu.au.
Gino VumbacaAustralian National Council on Drugs (ANCD), Canberra, Australia. gino@3vc.com.au.
Gloria LaiInternational Drug Policy Consortium, Bangkok, Thailand. glai@idpc.net.
Anand ChabungbamAsian Network of People who Use Drugs, Bangkok, Thailand. anand.chabungbam@anpud.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence indicates that detention of people who use drugs in compulsory centers in the name of treatment is common in Cambodia, China, Indonesia, Lao PDR, Malaysia, Myanmar, Philippines, Thailand, and Vietnam. The expansion of such practices has been costly, has not generated positive health outcomes, and has not reduced supply or demand for illicit drugs. United Nations agencies have convened several consultations with government and civil society stakeholders in order to facilitate a transition to voluntary evidence- and community-based drug dependence treatment and support services. In an effort to support such efforts, an informal group of experts proposes a three-step process to initiate and accelerate national-level transitions. Specifically, the working group recommends the establishment of a national multisectoral decision-making committee to oversee the development of national transition plans, drug policy reform to eliminate barriers to community-based drug dependence treatment and support services, and the integration of community-based drug dependence treatment in existing national health and social service systems.In parallel, the working group recommends that national-level transitions should be guided by overarching principles, including ethics, human rights, meaningful involvement of affected communities, and client safety, as well as good governance, transparency, and accountability. The transition also represents an opportunity to review the roles and responsibilities of various agencies across the public health and public security sectors in order to balance the workload and ensure positive results. The need to accelerate national-level transitions to voluntary community-based drug dependence treatment and support services is compelling--on economic, medical, sustainable community development, and ethical grounds--as extensively documented in the literature. In this context, the expert working group fully endorses initiation of a transition towards voluntary evidence- and community-based drug dependence treatment and support services across the region, as well as the steady scale-down of compulsory centers for drug users.Components of voluntary community-based drug dependence treatment and support services are being implemented in Cambodia, China, Indonesia, Malaysia, and Thailand. However, significant technical and financial support will be required to be allocated from national budgets and by international development agencies in order to complete the transition and reduce the reliance on detention of people who use drugs in Asia.

Indexed as

Community Health ServicesAsiaDrug UsersHumansPrisonersSubstance-Related Disorders

Identifiers

PMID26470779
PMCPMC4608322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.